Group 1 - The company, Shanghai Aopumai Biotechnology Co., Ltd., has participated in the establishment of an industrial fund named Shanghai Aochuang Xian Dao Venture Capital Partnership (Limited Partnership), with a total fundraising target of RMB 1 billion [2] - The company and/or its wholly-owned subsidiary, Aopumai Biological Engineering Co., Ltd., plan to contribute no more than 30% of the total fund size, which amounts to a maximum of RMB 300 million [2] - The fund will focus on early to mid-stage projects and mergers and acquisitions in the fields of biomanufacturing, pharmaceutical equipment and consumables, and biomedicine within China [2] Group 2 - The company has signed a partnership agreement with several entities, with an initial investment scale of RMB 500 million [2] - The fund management has completed the private investment fund registration procedures with the Asset Management Association of China and has obtained the Private Investment Fund Registration Certificate [4] - The company acknowledges potential risks in the fundraising process, including the possibility of not reaching the fundraising target due to partners not fulfilling their capital contributions [4]